Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: Post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second Danish Verapamil Infarction Trial studies

American Journal of Cardiology

Volumn 86, Issue 3, 2000, Pages 275-279

  Gibson, Robert S ^a   Hansen, Jørgen Fischer ^b   Messerli, Franz ^c   Schechtman, Kenneth B ^d   Boden, William E ^e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BISPEBJERG HOSPITAL   (Denmark)

^c TULANE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DILTIAZEM; DIURETIC AGENT; PLACEBO; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ELECTROCARDIOGRAM; FEMALE; HEART REINFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; CALCIUM CHANNEL BLOCKERS; DENMARK; DILTIAZEM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PULMONARY EDEMA; RETROSPECTIVE STUDIES; VERAPAMIL;

EID: 0033914611     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00913-9     Document Type: Article

References (24)

1. Gibson R.S. Non-Q wave myocardial infarction diagnosis, prognosis and management . Curr Probl Cardiol. 13:1988;9-72.
2. Wellford A.L., Ashcom T.L., Whitney E.J., Rubal B.J., Wellford L.A., Moody J.M. Jr. Changing presentation of coronary heart disease in an inpatient population within the U. S. military health care system. Military J Med. 158:1993;598-603.
3. Roberts R., Kleinman N.S. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set." Circulation. 89:1994;872-881.
4. Gibson R.S. Non-Q-wave myocardial infarction. Fuster V., Ross R., Topol E.J. Atherosclerosis and Coronary Artery Disease. 1996;1097-1123 Lippincott-Raven, Philadelphia.
5. Gibson R.S., Beller G.A., Gheorghiade M., Nygaard T.W., Watson D.D., Huey B.L., Sayre S.L., Kaiser D.L. The prevalence and clinical significance of residual myocardial ischemia two weeks after uncomplicated non-Q wave infarction a prospective natural history study . Circulation. 73:1986;1186-1198.
6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction results of the TIMI-3B trial . Circulation. 89:1994;1545-1556.
7. McCullough P.A., O'Neill W.W., Graham M., Stomel R.J., Rogers F., David S., Farhat A., Kazlauskaite R., Al-Zagoum M., Grines C.L. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion(MATE) trial. J Am Coll Cardiol. 32:1998;596-605.
8. Boden W.E., O'Rourke R.A., Crawford M.H., Blaustein A.S., Deedwania P.C., Zoble R.G., Wexler L.F., Kleiger R.E., Pepine C.J., Ferry D.R., Chow B.K., Lavori P.W. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 338:1998;1785-1792.
9. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 319:1988;385-392.
10. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II -DAVIT II). Am J Cardiol. 66:1990;779-785.
11. Cannon C.P. Diagnosis and management of patients with unstable angina. Curr Probl Cardiol. 24:1999;681-744.
12. Effects of recombinant hirudin (Lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation. Lancet. 353:1999;429-438.
13. Klein W., Buchwald A., Hillis W.S., Monrad S., Ganz G., Turpie G.G. Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for six weeks in the management of unstable coronary artery disease. Circulation. 96:1997;61-68.
14. Long-term low molecular mass versus heparin in unstable coronary artery disease. FRISC II prospective randomized multicenter study. Lancet. 354:1999;701-707.
15. Kereia Kes D.J., Kleiman N., Ferguson J.J. Sustained platelet glycoprotein 11b/111a blockade with oral xemilofiban in 170 patients after coronary stent deployment. Circulation. 96:1997;1117-1121.
16. Serruys P.W., O'Neill W.W., Knudtson M., Dreiling R., Anders R., Kleiman J.H., van Es G.-A. Restenosis following six months administration of xemilofiban, an oral IIb/IIIa antagonist a sub-study of the EXCITE trial . J Am Coll Cardiol. 33:(suppl A):1999;87A.
17. Anand S.S., Yusuf S. Randomized trial of oral anticoagulation therapy in patients with acute ischemic syndromes without ST elevation importance of good compliance . J Am Coll Cardiol. 33:(suppl A):1999;396A.
18. Gibson R.S. Current status of calcium channel blocking drugs after Q-wave and non-Q wave myocardial infarction. Circulation. 80:(suppl IV):1989;IV-107-IV-120.
19. Ryan T.J., Anderson J.L., Antman E.M., Braniff B.A., Brooks N.H., Califf R.M., Hillis L.D., Hiratzka L.F., Rapaport E., Riegel B.J., Russell R.O., Smith E.E. Jr, Weaver W.D. ACC/AHA guidelines for the management of patients with acute myocardial infarction a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines . J Am Coll Cardiol. 28:1996;1328-1428.
20. Rengo F., Carbonin P., Pahor M., DeCaprio L., Bernabei R., Ferrara N., Carosella L., Acanfora D., Parlati S., Vitale D. A controlled trial of verapamil after acute myocardial infarction results of the calcium antagonist reinfarction Italian study (CRIS) . Am J Cardiol. 77:1996;365-369.
21. Bonaduce D., Petretta M., Ianniciello A., Apicella C., Cavallaro V., Marciano F. Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction. Am J Cardiol. 79:1997;564-569.
22. Nicolau J.C., Ramires J.A., Maggioni A.P., Garzon S.A., Pinto M.A., Silva D.G., Nogueira P.R., Maia L.F., Vendramini P., Bassi I. Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase results of the Calcium Antagonist in Reperfusion Study (CARES) . Am J Cardiol. 78:1996;1049-1052.
23. Theroux P., Gregoire J., Chin C., Pelletier G., deGuise P., Juneau M. Intravenous diltiazem in acute myocardial infarction results of the diltiazem as adjunctive therapy to activase (DATA) trial . J Am Coll Cardiol. 32:1998;620-628.
24. Gibson R.S., Boden W.E., Theroux P., Strauss H.D., Pratt C.M., Gheorghiade M., Capone R.J., Crawford M.H., Schlant R.C., Kleiger R.E. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double blind, randomized, multicenter trial. N Engl J Med. 315:1986;423-429.